These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. 5-HT3 receptors and central effects of ethanol. Kostowski W Pol J Pharmacol; 1996; 48(3):243-54. PubMed ID: 9112659 [TBL] [Abstract][Full Text] [Related]
7. [Physiopathological and therapeutic perspectives on the new serotonin receptors: the type 4 receptor]. Lefebvre H Rev Med Interne; 2000 Aug; 21(8):661-3. PubMed ID: 10989490 [No Abstract] [Full Text] [Related]
9. The therapeutic potential of 5-HT6 receptor antagonists. Reavill C; Rogers DC Curr Opin Investig Drugs; 2001 Jan; 2(1):104-9. PubMed ID: 11527001 [No Abstract] [Full Text] [Related]
10. [Therapy of generalized tendomyopathy (fibromyalgia) caused by blocking 5-HT3 receptors]. Stratz T; Schochat T; Hrycaj P; Lacki J; Mennet P; Färber L; Schweiger C; Müller W Z Rheumatol; 1994; 53(6):335-8. PubMed ID: 7871905 [TBL] [Abstract][Full Text] [Related]
11. [Pilot study with 5-HT3 antagonists. Good outcome in fibromyalgia pain]. Stratz T; Müller W MMW Fortschr Med; 2002 Mar; 144(11):49. PubMed ID: 12066514 [No Abstract] [Full Text] [Related]
12. The clinical utility of pharmacological agents that act at serotonin receptors. Peroutka SJ; Sleight AJ; McCarthy BG; Pierce PA; Schmidt AW; Hekmatpanah CR J Neuropsychiatry Clin Neurosci; 1989; 1(3):253-62. PubMed ID: 2562495 [TBL] [Abstract][Full Text] [Related]
13. Role of 5-hydroxytryptamine3 (5-HT3) antagonists in the prevention of emesis caused by anticancer therapy. Karim F; Roerig SC; Saphier D Biochem Pharmacol; 1996 Sep; 52(5):685-92. PubMed ID: 8765466 [TBL] [Abstract][Full Text] [Related]
14. 5-HT3 receptors. Tyers MB Ann N Y Acad Sci; 1990; 600():194-202; discussion 202-5. PubMed ID: 2252310 [No Abstract] [Full Text] [Related]
16. 5-HT3 receptor antagonists vs traditional agents for the prophylaxis of postoperative nausea and vomiting. Loewen PS; Marra CA; Zed PJ Can J Anaesth; 2000 Oct; 47(10):1008-18. PubMed ID: 11032279 [TBL] [Abstract][Full Text] [Related]
17. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy. Gregory RE; Ettinger DS Drugs; 1998 Feb; 55(2):173-89. PubMed ID: 9506240 [TBL] [Abstract][Full Text] [Related]
18. 5-HT3 receptor antagonists: a new class of antiemetics. Lancet; 1987 Jun; 1(8548):1470-1. PubMed ID: 2885458 [No Abstract] [Full Text] [Related]
19. Advances in the design of 5-HT6 receptor ligands with therapeutic potential. Witty D; Ahmed M; Chuang TT Prog Med Chem; 2009; 48():163-224. PubMed ID: 21544960 [No Abstract] [Full Text] [Related]
20. 5-HT3 receptors: pharmacologic and therapeutic aspects. Gyermek L J Clin Pharmacol; 1995 Sep; 35(9):845-55. PubMed ID: 8786244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]